Cannabis Science and Technology Adds William Z. Levine, D.D.S., to Editorial Advisory Board
William Z. Levine, D.D.S.
Cannabis Science and Technology™ is proud to announce the addition of William Z. Levine, D.D.S., to its editorial advisory board.
“We look forward to having Dr. Levine joining the Cannabis Science and Technology™ advisory board,” said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, the parent company of Cannabis Science and Technology™. “His experience and contributions will be a great asset to our editorial staff as we continue to deliver unprecedented content to our readers.”
Levine is the founder of Izun Pharmaceuticals Corporation, a biopharmaceutical company specializing in botanical medicine. This area of specialty pharma develops pharmaceutical and health care products from plant-based sources. Levine, who received his D.D.S. degree and specialty training in periodontics from Columbia University, initially utilized this background to formulate novel oral care products to treat periodontal disease more effectively. Izun has also developed wound care products, oncology support products, and products targeting women’s health care.
Subsequently, recognizing the Izun expertise in botanicals, Levine applied this knowledge to the cannabis plant and established CannRx. In a short time, CannRx has developed novel targeted formulations, highly effective drug delivery systems specifically designed for cannabis, and completely new extraction systems.
As a member of the advisory board, Levine will work closely with the editorial team and the existing 16 board members to recommend topics, solicit and provide content, and share breaking news and information on the latest happenings in the cannabis industry.
For more information about the Cannabis Science and Technology™ editorial advisory board, click here.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
